Royal Bank of Canada
AKCA

Royal Bank of Canada’s Akcea Therapeutics Inc AKCA Stock Holding History

Royal Bank of Canada’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed – – 7231
2019
Q4 		$0 Buy
+1
New +$19 ﹤0.01% 7298
2019
Q3 		– Sell
-21
Closed – – 7368
2019
Q2 		$0 Sell
21
-40
-66% -$988 ﹤0.01% 7362
2019
Q1 		$2K Buy
+61
New +$1.78K ﹤0.01% 6583
2018
Q4 		– Sell
-110
Closed -$4K – 7365
2018
Q3 		$4K Buy
110
+46
+72% +$1.39K ﹤0.01% 6378
2018
Q2 		$2K Buy
64
+5
+8% +$119 ﹤0.01% 6303
2018
Q1 		$1K Buy
59
+57
+2,850% +$1.23K ﹤0.01% 6256
2017
Q4 		$0 Sell
2
-1,405
-100% -$27.5K ﹤0.01% 7097
2017
Q3 		$39K Buy
+1,407
New +$26K ﹤0.01% 5566

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada's AKCA Position: Q1 2020 in Review

Royal Bank of Canada sold out of Akcea Therapeutics Inc (AKCA) in Q1 2020, closing a stake of 1 share.

Royal Bank of Canada first reported a position in AKCA in Q3 2017 and held it in 8 quarters. The position peaked at $39K in Q3 2017. 77 funds tracked by Wall St. Rank hold AKCA as of Q1 2020.

  • Royal Bank of Canada reported no remaining Akcea Therapeutics Inc position as of Q1 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 1 Akcea Therapeutics Inc share in Q1 2020.
  • Royal Bank of Canada first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 8 quarters.
  • Royal Bank of Canada's Akcea Therapeutics Inc position peaked at $39K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q1 2020.

Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.